Linganisha mbinu

	Kipimo cha Athari za Fibromyalgia (Fibromyalgia Impact Questionnaire)	Kiwango cha Ubora wa Maisha wa Ugonjwa wa Figo
Nyanja	Matokeo ya Afya	Matokeo ya Afya
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1991	1994
Mwanzilishi	Cynthia S. Burckhardt et al.	Ron D. Hays et al.
Aina	Self-report symptom and functional impairment questionnaire	Self-report quality of life questionnaire
Chanzo asilia	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.	Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the Kidney Disease Quality of Life (KDQOL) instrument. Quality of Life Research, 3(5), 329-338.
Majina mbadala	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire	KDQOL, Kidney Disease QoL, KDQOL-SF
Zinazohusiana	4	4
Muhtasari	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.	The KDQOL is the most widely used quality of life measure for chronic kidney disease (CKD) patients, particularly those on dialysis. Developed by Ron Hays and colleagues in 1994, this multidimensional questionnaire (full version 134 items; short-form KDQOL-SF 36 items) measures kidney disease-specific impacts on physical function, emotional well-being, social participation, and treatment burden. It is the standard outcome measure in renal research and clinical practice.